Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Neoplasia (New York, N.Y.)|May 6, 2023
Mitochondrial rewiring drives metabolic adaptation to NAD(H) shortage in triple negative breast cancer cellsAgata Sofia Assuncao Carreira, Silvia Ravera, Chiara Zucal, et al.
Journal of Medicinal Chemistry|January 10, 2018
Interfering with HuR-RNA Interaction: Design, Synthesis and Biological Characterization of Tanshinone Mimics as Novel, Effective HuR InhibitorsLeonardo Manzoni, Chiara Zucal, Danilo Di Maio, et al.
Blood|June 25, 2025
Clinical and molecular features of immunodeficiency in patients with telomere biology disordersLuiz Fernando Bazzo Catto, Nidhi Aggarwal, Ruba Shalhoub, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Targeting MCL1-driven anti-apoptotic pathways to overcome hypomethylating agent resistance in RAS -mutated chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Feiyang Ma, Natthakan Thongon, et al.
Nature Communications|March 19, 2024
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromesJuan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Feiyang Ma, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
IL-1β-mediated inflammatory signaling drives ineffective erythropoiesis in early-stage myelodysplastic syndromesVera Adema, Irene Ganan-Gomez, Feiyang Ma, et al.
Cell Reports. Medicine|May 23, 2024
Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Natthakan Thongon, Juan Jose Rodriguez-Sevilla, et al.
Nature Communications|November 26, 2021
Hematopoiesis under telomere attrition at the single-cell resolutionNatthakan Thongon, Feiyang Ma, Andrea Santoni, et al.
Leukemia|July 21, 2025
Erythroid-predominant myelodysplastic neoplasms exhibit a distinct genomic landscape with poor outcomes after venetoclax-based therapyAlexandre Bazinet, Sanam Loghavi, Yue Wei, et al.
Blood Cancer Discovery|August 4, 2022
Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed SideroblastsVera Adema, Feiyang Ma, Rashmi Kanagal-Shamanna, et al.
Pageof 3